ESC Premium Access

Endpoint selection: who benefits from "net clinical benefit"?

Congress Session

About the speaker

Professor Darrel Francis

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

3 more presentations in this session

Superiority versus non-inferiority trials: the right answer for the appropriate question

Speaker: Professor R. Collins (Oxford, GB)

Thumbnail

Changing the paradigm: registry-based randomized trials

Speaker: Professor S. James (Uppsala, SE)

Thumbnail

Mendelian randomization: back to basics

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Thumbnail

Access the full session

Designing a clinical study - Learning from the masters

Speakers: Professor D. Francis, Professor R. Collins, Professor S. James, Professor B. Nordestgaard
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

ESC Premium Access

Will coronary atherosclerosis be eliminated?

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

This platform is supported by

logo Novo Nordisk